STOCK TITAN

Basel Medical (BMGL) CCO reports 10.2M shares held via Rainforest

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Basel Medical Group Ltd director and Chief Commercial Officer Tan Boon Chye (Darren) filed an initial ownership report showing indirect holdings in the company’s ordinary shares. A Singapore variable capital company, Rainforest Capital VCC, holds 10,205,229 ordinary shares on behalf of four subfunds.

One subfund, Basel Medical Fund, lists Tan Boon Chye as an ultimate beneficial owner, so he may be deemed to beneficially own a portion of these shares. He expressly disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest, and the filing does not report any new purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Tan Boon Chye
Role Chief Commercial Officer
Type Security Shares Price Value
holding Ordinary shares with no par value -- -- --
Holdings After Transaction: Ordinary shares with no par value — 10,205,229 shares (Indirect, See footnote)
Footnotes (1)
  1. [object Object]
Indirect ordinary shares after filing 10,205,229 shares Total ordinary shares indirectly held following the reported holding entry
Basel Medical Fund allocation 10,028,560 shares Ordinary shares held by Rainforest Capital VCC for Basel Medical Fund
Fan Mingchun allocation 23,256 shares Ordinary shares held by Rainforest Capital VCC for Fan Mingchun
Wei Hua allocation 46,512 shares Ordinary shares held by Rainforest Capital VCC for Wei Hua
Baselcorp Capital allocation 106,901 shares Ordinary shares held by Rainforest Capital VCC for Baselcorp Capital
variable capital company financial
"Rainforest Capital VCC is a variable capital company incorporated in Singapore"
ultimate beneficial owner financial
"Tan Boon Chye (Darren) is an ultimate beneficial owner of Basel Medical Fund"
The ultimate beneficial owner is the real person who ultimately owns or controls a company or asset, even if ownership is hidden behind layers of other companies, trusts, or nominees. Investors care because knowing who truly pulls the strings reveals who makes decisions and assumes risk, helps spot conflicts of interest or legal exposure, and improves trust and compliance — think of it as finding the owner behind a curtain rather than the front-facing spokesperson.
beneficially own financial
"may be deemed to beneficially own the shares that Rainforest Capital VCC holds"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
pecuniary interest financial
"disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein"
indirect financial
"ownership_type: "indirect" and ownership_code: "I""
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Tan Boon Chye

(Last)(First)(Middle)
6 NAPIER ROAD,
UNIT #02-10/11 GLENEAGLES MEDICAL CENTRE

(Street)
SINGAPORE258499

(City)(State)(Zip)

SINGAPORE

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Basel Medical Group Ltd [ BMGL ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares with no par value10,205,229ISee footnote(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Rainforest Capital VCC is a variable capital company incorporated in Singapore and holds 10,028,560 ordinary shares, 23,256 ordinary shares, 46,512 ordinary shares, and 106,901 ordinary shares of Basel Medical Group Ltd (the "Issuer") on behalf of Rainforest Capital VCC's four subfunds, Basel Medical Fund, Fan Mingchun, Wei Hua and Baselcorp Capital respectively. Tan Boon Chye (Darren) is an ultimate beneficial owner of Basel Medical Fund and may be deemed to beneficially own the shares that Rainforest Capital VCC holds in the Issuer. Tan Boon Chye (Darren) is also an officer and director of the Issuer. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ Tan Boon Chye04/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Basel Medical Group (BMGL) Form 3 by Tan Boon Chye report?

The Form 3 reports initial beneficial ownership for director and Chief Commercial Officer Tan Boon Chye. It shows indirect holdings of 10,205,229 ordinary shares through Rainforest Capital VCC’s subfunds, rather than any new share purchase or sale.

How many Basel Medical Group (BMGL) shares are held through Rainforest Capital VCC?

Rainforest Capital VCC holds 10,205,229 ordinary shares of Basel Medical Group Ltd. These are split among four subfunds holding 10,028,560, 23,256, 46,512 and 106,901 shares, according to the ownership footnote in the filing.

What is Tan Boon Chye’s relationship to Basel Medical Group (BMGL) and these shares?

Tan Boon Chye is a director and Chief Commercial Officer of Basel Medical Group Ltd. He is an ultimate beneficial owner of the Basel Medical Fund subfund, so he may be deemed to beneficially own some shares held via Rainforest Capital VCC.

Does the Basel Medical Group (BMGL) Form 3 show any insider buying or selling?

No, the Form 3 is an initial ownership statement and lists indirect holdings only. The transaction section uses a holding entry with no buy or sell code, so it does not report any purchase or sale of BMGL shares.

Why does Tan Boon Chye disclaim beneficial ownership of BMGL shares?

He disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest. The shares are held by Rainforest Capital VCC on behalf of four subfunds, so his interest is limited to the portion tied to Basel Medical Fund.

How are the Basel Medical Group (BMGL) shares allocated among Rainforest Capital VCC’s subfunds?

The filing states that Rainforest Capital VCC holds 10,028,560 shares for Basel Medical Fund, 23,256 for Fan Mingchun, 46,512 for Wei Hua, and 106,901 for Baselcorp Capital, all in Basel Medical Group Ltd.